Filing Details
- Accession Number:
- 0001415889-25-015263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-02 17:35:08
- Reporting Period:
- 2025-05-30
- Filing Date:
- 2025-06-02
- Accepted Time:
- 2025-06-02 17:35:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1392380 | Gevo Inc. | GEVO | Industrial Organic Chemicals (2860) | 870747704 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1512143 | Michael Christopher Ryan | C/O Gevo, Inc. 345 Inverness Drive South Building C, Suite 310 Englewood CO 80112 | President & Coo | No | No | No | No |
Transaction Summary
Sold: | 73,934 shares | Avg. Price: $1.28 | Total Value: $94,783.39 |
Number of Shares After Transactions: | 1,510,000 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-30 | 73,934 | $1.28 | 1,510,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 22,042 | Indirect | By 401(k) Plan |
Footnotes
- Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.2512 to $1.3050 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Between October 1, 2024 and May 30, 2025, the reporting person (i) had a decrease of 12,684.88 shares under the issuer's 401(k) plan to reconcile an error due to an excess match, (ii) acquired 7,885.71 shares of the issuer's common stock under the issuer's 401(k) plan, and (iii) disposed of 79.73 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated May 22, 2025.